Form D · Biotechnology

Flow Pharma, Inc.

Warrensville Heights, OH · CIK 0001732825

Offering snapshot reported Aug 8, 2024 · SEC filing

Reported sold
$225K
Offering amount: $40M
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 31, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$113K$225KAug 1, 2024: $50,000.00Aug 1, 2024Aug 8, 2024: $225,000.00Aug 8, 2024

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$50,000 → $225,000
  • Reported investors1 → 3

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 8, 2024Amendment$225,000$175,000vs Aug 1, 20243SEC filing
Aug 1, 2024Initial$50,000No comparison1SEC filing
Nov 2, 2022Initial$180,000No comparison8SEC filing
Feb 28, 2018Initial$1,149,710No comparison17SEC filing
Feb 28, 2018Initial$2,260,000No comparison42SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-520397

Source: Form D, filed Aug 8, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Thomas Barnish Executive
Tikoes Blankenberg Director
Tom Brady Executive
Thomas Brady Executive
Stephen Farr Director
Charles Vincent Herst Executive
Lester John Lloyd Director, Executive
Babatunde Otulana Director
Reid Martin Rubsamen Director, Executive
Pamela Steele Director
Anthony Tufaro Director
Gil Van Bokkelen Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
4829 Galaxy Parkway Suite K
Warrensville Heights, OH, 44128